News Analysis

Most Recent

HOUSTON A variety of motives are behind several recent drug company announcements of donations of HIV/AIDS drugs to African countries. Certainly, something needs to be done to control existing cases of HIV/AIDS, in addition to the lifestyle changes that would reduce the number of new AIDS cases. By the end of this year, 36.1 million people will be living with HIV or AIDS, according to the Joint United Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization (WHO).WHO and UNAIDS res

0 Comments

Why did the chicken cross the DNA?

By | December 6, 2000

Advances in transgenics and drug production are foreseen using chicken eggs, says the Roslin Institute. But why chickens?

0 Comments

Banking on genes

By | December 4, 2000

Various high-profile genetic projects around the world are pushing the barriers of research. But are they trespassing on human rights?

0 Comments

Drug metabolites can now be patented

By | November 29, 2000

HOUSTON Bristol-Myers Squibb Company unveiled both a scientific achievement and a patent strategy that, if used by other drug companies, could delay introduction of cheaper generic versions of hundreds of patented drugs. Typically, after patents expire and generic versions of a drug become available, most drugs lose up to 80% of sales during the first year they face generic competition, according to Barbara Ryan, a drug industry analyst with Deutsche Banc Alex Brown. US patents on drugs with sal

0 Comments

Potential AIDS epidemic in Eastern Europe

By | November 29, 2000

Experts fear that Eastern Europe could experience an AIDS epidemic similar to that seen in Africa.

0 Comments

Online prescription drugs

November 23, 2000

A new website from the US Food and Drug Administration (FDA) warns that many online pharmacies provide legitimate prescription services but that some questionable sites may make purchasing medicines online risky.On its website dedicated to this topic, the FDA highlights some of the problems associated with purchasing prescriptions online. These include sub-standard products; little or no quality control; possibility of an incorrect diagnosis by sites that inappropriately diagnose and prescribe o

0 Comments

Zebrafish genome to be sequenced

By | November 23, 2000

The genome of the zebrafish is to be sequenced at the Wellcome Trust's Sanger Centre near Cambridge, UK.

0 Comments

110m into post-genomic research

By | November 22, 2000

500,000 people will help research councils to solve post-genomic puzzles.

0 Comments

Children's parents sue hospital over genetics patent

By | November 22, 2000

Families of children suffering a degenerative brain disease are suing the hospital and researchers who used their children's blood and tissue to identify and patent the gene responsible for the disorder.

0 Comments

Italy: a GMO-free country?

By | November 21, 2000

The Italian Minister for Agricultural and Forestry Policy has made it clear he intends to ban GMOs of agricultural interest - but will he manage to sway the Italian public?

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech